Events September 22, 2005

Disclosure, Regulatory and Governance Issues Affecting Life Sciences Companies

Goodwin Procter invites you to join us for this discussion, topics of which will include the increased regulatory focus on disclosure relating to clinical trials and the progress of FDA approval of new drug applications; the drive to increase the coordination of the FDA and the SEC in rooting out inaccurate disclosures; and the securities and shareholder litigation risks faced by life sciences companies, including the implications of the Delaware Chancery Court’s recent Disneydecision, as well as what companies can do to insure and indemnify their officers and directors adequately. Massachusetts Biotech Council (MBC), MassMedic, Mass Insight Corporation, MIT Entrepreneurship Center and TiE-Boston are event sponsors. Brian Pastuszenski and Larry Wittenberg are panelists.

Click here to view the program's invitation.